0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Dopaminergic Neurons in Periventricular and Arcuate Nuclei of Proestrous and Ovariectomized Rats: Endogenous Diurnal Rhythm of Fos-Related Antigens Expression

      ,

      Neuroendocrinology

      S. Karger AG

      Catecholamines, Periventricular nucleus, Arcuate nucleus, Fos, Circadian rhythms, Prolactin

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The expression of Fos-related antigens (FRAs) in the A<sub>[2</sub> and the A<sub>14</sub> hypothalamic dopaminergic neurons was compared throughout the day in proestrous (PRO) and ovariectomized (OVX) rats to establish the relationship between secretion of prolactin (PRL) and dopaminergic neuronal activation. Animals with intact ovaries were sacrificed at 11:00, 13:00, 15:00, 17:00 and 21:00 h on the day of proestrus and 06:00 and 09:00 h in the morning of estrus. OVX animals were sacrificed at the same time points on the 12th day after surgery. Double-label immunocytochemistry was performed by using antibodies against FRAs as markers of tonic neuronal activity and tyrosine hydroxylase to identify dopaminergic neurons. Serum PRL levels were determined by radioimmunoassay. A pattern of FRAs expression was present in the A<sub>14</sub> and A<sub>12</sub> neurons of PRO rats. The incidence of FRAs expressing neurons was the highest in the first half of the day when the PRL levels were low, and decreased prior to the surge of serum PRL during the afternoon. This pattern was present in the dopaminergic neurons of the periventricular nucleus (A<sub>12</sub>), and in all portions of the arcuate nucleus (A<sub>12</sub>) except the ventrolateral portion of the middle arcuate nucleus. A similar pattern of FRAs expression existed in the A<sub>14</sub> and A<sub>12</sub>neurons of OVX rats in spite of that there were no detectable changes in serum PRL levels. However, the amplitude of decrease in the incidence of FRAs-labeled neurons was lower in OVX than in PRO rats. These data suggested that similar to the control of hypothalamic PRL releasing factors, the activation/deactivation pattern of the A<sub>12</sub> and the A<sub>14</sub> neurons is governed by a seemingly endogenous rhythmic input. The incidence of this rhythm is independent of the reproductive state, but its amplitude is enhanced by ovarian steroids. The disparity between the FRAs expression and serum PRL levels in OVX rats indicated that the effect of this endogenous dopaminergic rhythm upon PRL secretion is dependent on the ovarian steroid background.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1997
          1997
          09 April 2008
          : 65
          : 6
          : 436-445
          Affiliations
          Department of Biological Science, Florida State University, Tallahassee, Fla., USA
          Article
          127207 Neuroendocrinology 1997;65:436–445
          10.1159/000127207
          9208406
          © 1997 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Categories
          Reproductive Hormones

          Comments

          Comment on this article